Replies to post #54 on Nucana Plc (NCNA)

[chemist72]

NCNA has until 5/6/2024 to attain NASDAQ's minimum bid requirement of $1.00.

So though not inevitable, I'd agree that the possibility of an RS is highly likely.

Another possibility is for NCNA to partner with a large pharma company to begin one or more clinical trials with one or more of their patented drugs. If they haven't had any conversations about this up to now, I'd say it's highly unlikely any partnership agreement could be finalized in the ~1 month remaining before they will be subject to delisting by NASDAQ.

Needless to say, I'm very glad I was able to sell all my NCNA shares during the recent runup. And I likely won't be buying any shares up to May 6. If NCNA does decide to do a reverse split to remain quoted on NASDAQ, I will reconsider my stance.